The University of Southampton
University of Southampton Institutional Repository

The MAP-kinase interacting kinases (Mnks) as targets in cancer

The MAP-kinase interacting kinases (Mnks) as targets in cancer
The MAP-kinase interacting kinases (Mnks) as targets in cancer
The Mnks appear to play an important role in tumour development, but are not essential for normal cell growth and development. This makes them attractive targets for designing anti-cancer treatments. The Mnks are directly downstream of the RAS-RAF-MEK-ERK pathway, a pathway that is frequently overactive in cancer cells. The Mnks bind to eIF4G, which is part of the translation initiation complex, and are the only kinases known to phosphorylate the 5’ mRNA cap-binding protein eIF4E. Despite numerous studies linking this phosphorylation event to cancer, its precise role in cancer remains unclear. The lack of progress in developing our understanding of the role the Mnks is largely down to the absence of a selective and potent Mnk inhibitor. Presented here are the results of experiments carried out using a novel Mnk inhibitor, Mnk-I1. These results are also backed up with the results of experiments using cells – Mouse Embryonic Fibroblasts (MEFs) - that have had the Mnks genetically knocked out. What the results show, is that Mnk kinase activity appears to play a key role in cancer cell migration. The mechanism appears to involve an important role for Mnk kinase activity in the translation of vimentin mRNA into protein and in preventing the degradation of the vimentin protein: an established marker of cells that have undergone Epithelial-Mesenchymal Transition (EMT) and become motile. The results presented in the last chapter focus on whether the Mnks might be suitable targets for overcoming acquired resistance to the MEK inhibitor AZD6244. In the context of a BRAF600E amplification, Mnk-I1 appeared to have a small antiproliferative effect in one cancer cell line tested; however, there was no effect on the proliferation of a cancer cell line with a KRAS13D amplification. Included in this set of data is an interesting effect of Mnk-I1 on increasing P-Mnk1 levels.
Beggs, James
81f06c8e-44b8-48ea-ad1d-7bf109f1ec8b
Beggs, James
81f06c8e-44b8-48ea-ad1d-7bf109f1ec8b
Proud, Christopher
e98b395e-8ce8-465c-bbcb-76026acea42b

Beggs, James (2015) The MAP-kinase interacting kinases (Mnks) as targets in cancer. University of Southampton, Biological Sciences, Doctoral Thesis, 213pp.

Record type: Thesis (Doctoral)

Abstract

The Mnks appear to play an important role in tumour development, but are not essential for normal cell growth and development. This makes them attractive targets for designing anti-cancer treatments. The Mnks are directly downstream of the RAS-RAF-MEK-ERK pathway, a pathway that is frequently overactive in cancer cells. The Mnks bind to eIF4G, which is part of the translation initiation complex, and are the only kinases known to phosphorylate the 5’ mRNA cap-binding protein eIF4E. Despite numerous studies linking this phosphorylation event to cancer, its precise role in cancer remains unclear. The lack of progress in developing our understanding of the role the Mnks is largely down to the absence of a selective and potent Mnk inhibitor. Presented here are the results of experiments carried out using a novel Mnk inhibitor, Mnk-I1. These results are also backed up with the results of experiments using cells – Mouse Embryonic Fibroblasts (MEFs) - that have had the Mnks genetically knocked out. What the results show, is that Mnk kinase activity appears to play a key role in cancer cell migration. The mechanism appears to involve an important role for Mnk kinase activity in the translation of vimentin mRNA into protein and in preventing the degradation of the vimentin protein: an established marker of cells that have undergone Epithelial-Mesenchymal Transition (EMT) and become motile. The results presented in the last chapter focus on whether the Mnks might be suitable targets for overcoming acquired resistance to the MEK inhibitor AZD6244. In the context of a BRAF600E amplification, Mnk-I1 appeared to have a small antiproliferative effect in one cancer cell line tested; however, there was no effect on the proliferation of a cancer cell line with a KRAS13D amplification. Included in this set of data is an interesting effect of Mnk-I1 on increasing P-Mnk1 levels.

PDF
thesis.pdf - Other
Download (11MB)

More information

Published date: September 2015
Organisations: University of Southampton, Centre for Biological Sciences

Identifiers

Local EPrints ID: 390651
URI: https://eprints.soton.ac.uk/id/eprint/390651
PURE UUID: b6352f18-380c-42d8-ba74-d6cbc12765f3

Catalogue record

Date deposited: 04 Apr 2016 12:13
Last modified: 18 Jul 2017 04:25

Export record

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of https://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×